Corona Remedies Announces 22nd AGM and FY26 Annual Report

Corona Remedies Ltd has announced its 22nd Annual General Meeting (AGM) scheduled for July 9, 2026, to be held via video conferencing. The company is also distributing its Annual Report for the Financial Year 2025-26. Shareholders who have not registered their email IDs will receive a letter with a weblink to access the report and AGM notice. The Board of Directors has recommended a dividend of ₹10 per equity share, subject to member approval at the AGM. Shareholders are urged to update their KYC details for electronic dividend payments and to facilitate digital communication.